Indaptus Therapeutics Reports Encouraging New Safety Data for Decoy20 Clinical Program; Company Expands Enrollment of Patients on Weekly Dosing at Two Different Doses
Indaptus Therapeutics報告了Decoy20臨床項目的令人鼓舞的新安全數據;公司擴大了兩個不同劑量的每週給藥病人的招募
Indaptus Therapeutics Reports Encouraging New Safety Data for Decoy20 Clinical Program; Company Expands Enrollment of Patients on Weekly Dosing at Two Different Doses
Indaptus Therapeutics報告了Decoy20臨床項目的令人鼓舞的新安全數據;公司擴大了兩個不同劑量的每週給藥病人的招募
譯文內容由第三人軟體翻譯。